CD152 Recombinant Protein

Reference: PX-P4108-100
Product nameCD152 Recombinant Protein
Uniprot IDP16410
Uniprot linkhttp://www.uniprot.org/uniprot/P16410
Origin speciesHomo sapiens (Human)
Expression systemEukaryotic expression
SequenceMACLGFQRHKAQLNLATRTWPCTLLFFLLFIPVFCKAMHVAQPAVVLASSRGIASFVCEYASPGKATEVRVTVLRQADSQVTEVCAATYMMGNELTFLDDSICTGTSSGNQVNLTIQGLRAMDTGLYICKVELMYPPPYYLGIGNGTQIYVIDPEPCPDSD
Molecular weight18.51kDa
Protein delivered with Tag?C-terminal His Tag
Purity estimated>90% by SDS-PAGE
BufferPBS pH7.5
Delivery conditionDry Ice
Storage conditionStore at - 20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage.
BrandProteoGenix
Host speciesMammalian cells
ApplicationsELISA,WB
Fragment TypeMet1~Asp161
Aliases /SynonymsCD152
ReferencePX-P4108
NoteFor research use only

Description of CD152 Recombinant Protein

General information on CD152 Recombinant Protein:

CD152, also known as CTLA4 and cytotoxic T lymphocyte protein 4, is a single-pass type I membrane protein and a member of the immunoglobulin superfamily. It is the second member of the CD28 receptor. The ligands or counterreceptors of these two proteins belong to the B7, CD8 (B7-1) and CD86 (B7-2) families. CTLA4 delivers inhibitory signals to T lymphocytes, while CD28 delivers stimulatory signals. Intracellular CTLA4 is also present in regulatory T cells and may play an important role in its function. CD152 antigen or cytotoxic T lymphocytes (CTLA-4) are important receptors involved in downregulating T-cell activation. Due to its far-reaching inhibitory effect, CD152 is considered a candidate solid acceptable for autoimmunity and a convincing target for cancer immunotherapy. In particular, recent evidence suggests that CD152 is also important in homeostasis and the function of population suppressor cells called regulatory T cells (Treg).

Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb binds to CD152 Recombinant Protein in indirect ELISA Assay

Immobilized CD152 Recombinant Protein (cat. No.PX-P4108) at 0.5µg/mL (100µL/well) can bind to Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb (cat. No.PX-TA1177) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “CD152 Recombinant Protein”

Your email address will not be published. Required fields are marked *

Related products

Tremelimumab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade
Biosimilar

Tremelimumab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade

PX-TA1177 400€
Zalifrelimab  Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade
Biosimilar

Zalifrelimab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade

PX-TA1559 400€
Nurulimab  Biosimilar – Anti-CTLA4 mAb – Research Grade
Biosimilar

Nurulimab Biosimilar – Anti-CTLA4 mAb – Research Grade

PX-TA1597 400€
Botensilimab Biosimilar – Anti-CTLA4 mAb – Research Grade
Biosimilar

Botensilimab Biosimilar – Anti-CTLA4 mAb – Research Grade

PX-TA1647 400€
Cadonilimab Biosimilar – Anti-PDCD1;CTLA4 mAb – Research Grade
Biosimilar

Cadonilimab Biosimilar – Anti-PDCD1;CTLA4 mAb – Research Grade

PX-TA1648 400€
Erfonrilimab Biosimilar – Anti-CD274;CTLA4 mAb – Research Grade
Biosimilar

Erfonrilimab Biosimilar – Anti-CD274;CTLA4 mAb – Research Grade

PX-TA1665 400€
Lorigerlimab Biosimilar – Anti-CTLA4 & PD1 mAb – Research Grade
Biosimilar

Lorigerlimab Biosimilar – Anti-CTLA4 & PD1 mAb – Research Grade

PX-TA1765 400€
Tuvonralimab Biosimilar – Anti-CTLA4 mAb – Research Grade
Biosimilar

Tuvonralimab Biosimilar – Anti-CTLA4 mAb – Research Grade

PX-TA1781 400€
Bavunalimab Biosimilar – Anti-LAG3;CTLA4 mAb – Research Grade
Biosimilar

Bavunalimab Biosimilar – Anti-LAG3;CTLA4 mAb – Research Grade

PX-TA1813 400€
Human CD138/SDC1 Monoclonal Antibody
Monoclonal Antibody

Human CD138/SDC1 Monoclonal Antibody

FHD30810 330€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products